Vanguard Fiduciary Trust
SNDX icon

Vanguard Fiduciary Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
633,509
+32,992
+5% +$686K ﹤0.01% 1634
2026
Q1 		$14M Buy
+600,517
New +$13M ﹤0.01% 1531

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Fiduciary Trust's SNDX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Syndax Pharmaceuticals (SNDX) stake by 5.5% in Q2 2026, buying an estimated $686K and bringing the position to 633,509 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Vanguard Fiduciary Trust first reported a position in SNDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $14M in Q1 2026. 240 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Vanguard Fiduciary Trust held 633,509 shares of Syndax Pharmaceuticals worth $13.8M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 32,992 Syndax Pharmaceuticals shares in Q2 2026, an estimated $686K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1634 holding.
  • Vanguard Fiduciary Trust first reported a position in Syndax Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Syndax Pharmaceuticals position peaked at $14M in Q1 2026.
  • 240 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.